Latest AI and machine learning research in oncology/hematology for healthcare professionals.
OBJECTIVE: Recently, deep learning (DL)-based reconstruction methods have been introduced into clini...
BACKGROUND: Optimal patient selection for the most effective BTK inhibitor (BTKi) partner of venetoc...
Tailoring cancer treatment to the primary tumor site is essential for optimal outcomes, yet identify...
BACKGROUND: Implant-based reconstruction failure remains a significant complication following breast...
Chemotherapy-induced madarosis significantly impacts patient quality of life, yet current assessment...
Hepatocellular carcinoma (HCC) is a highly lethal malignancy with high invasiveness and metastasis. ...
Brain tumor classification from magnetic resonance imaging (MRI) remains challenging because tumor a...
Colorectal liver metastases (CRLM) remain a major cause of cancer-related mortality, with imaging pl...
Neoadjuvant therapy (NAT) has emerged as a standard treatment strategy for locally advanced breast c...
Personalized cancer vaccines have re-emerged as a promising strategy in precision immunotherapy, dri...
OBJECTIVE: This review critically evaluates the diagnostic potential of salivary biomarkers in oral ...
Digital twin technology has emerged as a transformative innovation in healthcare, offering virtual r...
BACKGROUND: The precise prognostic stratification of intrahepatic cholangiocarcinoma (iCCA) remains ...
Early and reliable detection of brain tumors from magnetic resonance imaging (MRI) is essential for ...
BACKGROUND: Artificial intelligence (AI) technologies, particularly large language models (LLMs) suc...
Glioma is a highly malignant brain tumor with limited treatment options. We employed the Computation...
With global population aging and increased life expectancy, bone diseases affect a substantial propo...
Contemporary risk models in chronic myelomonocytic leukemia (CMML) focus on the prognostic relevance...
OBJECTIVES: Alcohol is a group one carcinogen and contributes to breast cancer risk for women. Aware...
The discovery of selective small-molecule inhibitors for pharmacologically underexplored kinases rem...
BACKGROUND: Accurate differentiation between non-small cell lung cancer (NSCLC) and small cell lung ...